يعرض 1 - 6 نتائج من 6 نتيجة بحث عن '"INFECTION"', وقت الاستعلام: 1.25s تنقيح النتائج
  1. 1
    تقرير
  2. 2
    تقرير

    المصدر: Renaud L, Lebozec K, Voors-Pette C, Dogterom P, Blld P, Jandrot Perrus M, Pletan Y, Machacek M. Populatn Pharmacoket/Pharmacodynam Modelg of Glenzocab (ACT017) a Glycoprote Vhor of Collagen-duced Platelet Aggregatn. J Cl Pharmacol. 2020 Sep;60(9):1198-1208. do 10.1002/jcph.1616. Epub 2020 Jun 4.
    Voors-Pette C, Lebozec K, Dogterom P, Julln L, Blld P, Ferlan P, Renaud L, Favre-Bulle O, Avenard G, Machacek M, Pletan Y, Jandrot-Perrus M. Safety and Toleraby, Pharmacokets, and Pharmacodynams of ACT017, an Antlatelet GPV(Glycoprote V Fab. Arterscler Thromb Vasc Bl. 2019 May;39(5):956-964. do 10.1161/ATVBAHA.118.312314.
    A Randomized, Double Blind, Multicenter, Placebo Controlled, Parallel Group, Exploratory Efficacy and Safety Study of Glenzocimab in SARS-Cov-2-related Acute Respiratory Distress Syndrome

  3. 3
    تقرير

    المصدر: Electrical Impedance Tomography: Collapse in Dependent Areas as a Predictor of Response to Prone Position Ventilation in COVID-19 Acute Respiratory Distress Syndrome

  4. 4
    تقرير

    المصدر: Efficacy of Injectable Methylprednisolone Sodium Succinate in the Treatment of Patients With Signs of Severe Acute Respiratory Syndrome Under the New Coronavirus (SARS-CoV2): a Phase IIb, Randomized, Double-blind, Placebo-controlled, Clinical Trial.

  5. 5
    تقرير

    المصدر: Phase IIb Study to Evaluate the Efficacy and Safety of Chloroquine Diphosphate in the Treatment of Patients With Comorbidities, Without Severe Acute Respiratory Syndrome, Under the New Coronavirus (SARS-CoV2): a Double-blind, Randomized, Placebo-controlled Clinical Trial

  6. 6
    تقرير